NANCY BERMAN: Open Payments
NPI 1174530398 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,085 in 35 payments from 9 companies in 2025. Trend: 2023 $12,547 · 2024 $4,965 · 2025 $11,085
Speaker / faculty: $4,575Travel & lodging: $2,947Consulting: $2,520Food & beverage: $1,043
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $4,300 |
| Merck Sharp & Dohme LLC | 11 | $4,277 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $1,987 |
| Lilly USA, LLC | 3 | $157 |
| Sumitomo Pharma America, Inc. | 2 | $104 |
| Amgen Inc. | 2 | $97 |
| Novo Nordisk Inc | 1 | $95 |
| ABBVIE INC. | 2 | $53 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Veozah, Lynkuet, M-M-R II, ZEPBOUND, EVENITY, GEMTESA, RINVOQ, MYFEMBREE.
Industry payments across MI — which companies pay providers there.
